Catalyst Wire Dossier Catalyst Wire Dossier

VX-661 (lumacaftor)

lumacaftor · Vertex Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-661 (lumacaftor), covering 2018-06-12 to 2018-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor [Phase 3]

See pricing